VICP Registry Case Source Bundle Canonical URL: https://vicp-registry.org/case/USCOURTS-cofc-1_24-vv-00060 Package ID: USCOURTS-cofc-1_24-vv-00060 Petitioner: Amanda Connor Filed: 2024-01-17 Decided: 2025-09-24 Vaccine: Tdap; later COVID-19 noted in stipulation Vaccination date: 2022-10-20 Condition: shoulder injury related to vaccine administration (SIRVA) Outcome: compensated Award amount USD: 30000 AI-assisted case summary: On January 17, 2024, Amanda Connor filed a petition alleging that a tetanus, diphtheria, and acellular pertussis (Tdap) vaccination on or about October 20, 2022 caused a shoulder injury related to vaccine administration. The stipulation also notes that she received a COVID-19 vaccine on January 6, 2023, outside the Vaccine Injury Table. Respondent denied that Ms. Connor's alleged SIRVA began within the Table timeframe, denied that the Tdap vaccine caused her shoulder injury or any other injury, and denied that her current disabilities were vaccine sequelae. The public stipulation decision does not describe the first symptom, treatment history, imaging, daily-life effects, expert evidence, or medical mechanism. On September 24, 2025, Chief Special Master Brian H. Corcoran adopted the parties' stipulation and awarded Ms. Connor a lump sum of $30,000.00 through counsel's IOLTA account. The stipulation included waiver language for any possible Countermeasures Injury Compensation Program claim involving the later COVID-19 vaccine alone or in combination with the Tdap vaccination. Theory of causation field: Tdap vaccine on or about October 20, 2022, alleged SIRVA; stipulation also notes a later January 6, 2023 COVID-19 vaccine and waiver/withdrawal of related CICP claims if any. COMPENSATED by stipulation. Respondent denied Table-timeframe onset, Tdap causation, and sequelae. Public decision gives no onset/treatment details. Award: $30,000 lump sum for all Section 15(a) damages, ACH to counsel IOLTA. Chief Special Master Corcoran September 24, 2025. Attorney Christopher J. Webb; respondent Mallori Browne Openchowski. Public staged source text: ================================================================================ DOCUMENT 1: USCOURTS-cofc-1_24-vv-00060-0 Date issued/filed: 2025-10-31 Pages: 8 Docket text: PUBLIC DECISION (Originally filed: 09/24/2025) regarding 34 DECISION Stipulation/Proffer Signed by Chief Special Master Brian H. Corcoran. (nh) Service on parties made. -------------------------------------------------------------------------------- Case 1:24-vv-00060-UNJ Document 38 Filed 10/31/25 Page 1 of 8 In the United States Court of Federal Claims OFFICE OF SPECIAL MASTERS No. 24-0060V AMANDA CONNOR, Chief Special Master Corcoran Petitioner, Filed: September 24, 2025 v. SECRETARY OF HEALTH AND HUMAN SERVICES, Respondent. Christopher J. Webb, Black McLaren Jones Ryland & Griffee, Memphis, TN, for Petitioner. Mallori Browne Openchowski, U.S. Department of Justice, Washington, DC, for Respondent. DECISION ON JOINT STIPULATION1 On January 17, 2024, Amanda Connor filed a petition for compensation under the National Vaccine Injury Compensation Program, 42 U.S.C. §300aa-10, et seq.2 (the “Vaccine Act”). Petitioner alleges that she suffered a shoulder injury related to vaccine administration (“SIRVA”) following a Tdap vaccination she received on October 20, 2022. Petition at 1; Stipulation, filed at September 23, 2025, ¶¶ 2, 4. Petitioner further alleges that she has suffered the residual effects of her vaccine-related injury for more than six months. Petition at ¶ 10; Stipulation at ¶ 4. “Respondent denies that Petitioner suffered the onset of her alleged SIRVA within the Table timeframe; denies that the Tdap vaccine caused Petitioner’s alleged shoulder injury or any other injury and further denies that her current disabilities are a sequela of a vaccine-related injury.” Stipulation at ¶ 6. Nevertheless, on September 23, 2025, the parties filed the attached joint stipulation, stating that a decision should be entered awarding compensation. I find the 1 Because this Decision contains a reasoned explanation for the action taken in this case, it must be made publicly accessible and will be posted on the United States Court of Federal Claims' website, and/or at https://www.govinfo.gov/app/collection/uscourts/national/cofc, in accordance with the E-Government Act of 2002. 44 U.S.C. § 3501 note (2018) (Federal Management and Promotion of Electronic Government Services). This means the Decision will be available to anyone with access to the internet. In accordance with Vaccine Rule 18(b), Petitioner has 14 days to identify and move to redact medical or other information, the disclosure of which would constitute an unwarranted invasion of privacy. If, upon review, I agree that the identified material fits within this definition, I will redact such material from public access. 2 National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755. Hereinafter, for ease of citation, all section references to the Vaccine Act will be to the pertinent subparagraph of 42 U.S.C. § 300aa (2018). Case 1:24-vv-00060-UNJ Document 38 Filed 10/31/25 Page 2 of 8 stipulation reasonable and adopt it as my decision awarding damages, on the terms set forth therein. Pursuant to the terms stated in the attached Stipulation, I award the following compensation: A lump sum of $30,000.00, to be paid through an ACH deposit to Petitioner’s counsel’s IOLTA account for prompt disbursement to Petitioner. Stipulation at ¶ 8. This amount represents compensation for all items of damages that would be available under Section 15(a). Id. I approve the requested amount for Petitioner’s compensation. In the absence of a motion for review filed pursuant to RCFC Appendix B, the Clerk of Court is directed to enter judgment in accordance with this decision.3 IT IS SO ORDERED. s/Brian H. Corcoran Brian H. Corcoran Chief Special Master 3 Pursuant to Vaccine Rule 11(a), entry of judgment can be expedited by the parties’ joint filing of notice renouncing the right to seek review. 2 Case 1:24-vv-00060-UNJ Document 38 Filed 10/31/25 Page 3 of 8 IN THE UNITED STATES COURT OF FEDERAL CLAIMS OFFICE OF SPECIAL MASTERS AMANDA CONNOR, Petitioner, No. 24-60V Chief Special Master Corcoran v. SPU SECRETARY OF HEALTH AND HUMAN SERVICES, Respondent. STIPULATION The parties hereby stipulate to the following matters: 1. Petitioner, Amanda Connor, filed a petition for vaccine compensation under the National Vaccine Injury Compensation Program, 42 U.S.C. § 300aa-10 to 34 (the "Vaccine Program"). The petition seeks compensation for injuries allegedly related to petitioner's receipt of the Tetanus-diphtheria-acellular pertussis ("Tdap") vaccine, which vaccine is contained in the Vaccine Injury Table (the "Table"), 42 C.F.R. § 100.3 (a). 2. Petitioner received a Tdap vaccine on or about October 20, 2022. 1 3. The vaccine was administered within the United States. 1 On January 6, 2023, petitioner received a COVID-19 vaccine. Vaccines against COVID-19 are not contained in the Vaccine Injury Table. See 42 U.S.C. § 300aa-14 and 42 C.F.R. § 100.3(a). Pursuant to the declaration issued by the Secretary of Health and Human Services under the Public Readiness and Emergency Preparedness Act (42 U.S.C. §§ 247d-6d, 247d-6e), claims for alleged injuries from COVID-19 countermeasures, including vaccines, may be compensable under the Countermeasures Injury Compensation Program ("CICP"). See 85 Fed. Reg. 15198, 15202 (March 17, 2020). Page 1 of 6 Case 1:24-vv-00060-UNJ Document 38 Filed 10/31/25 Page 4 of 8 4. Petitioner alleges that she suffered a Shoulder Injury Related to Vaccine Administration ("SIRVA") as a consequence of the Tdap immunization she received on or about October 20, 2022, and further alleges that she suffered the residual effects of this injury for more than six months. 5. Petitioner represents that there has been no prior award or settlement of a civil action for damages on her behalf as a result of her condition. 6. Respondent denies that petitioner suffered the onset of her alleged SIRVA within the Table timeframe; denies that the Tdap vaccine caused petitioner's alleged shoulder injury or any other injury and further denies that her current disabilities are a sequela of a vaccine-related injury. 7. Maintaining their above-stated positions, the parties nevertheless now agree that the issues between them shall be settled and that a decision should be entered awarding the compensation described in paragraph 8 of this Stipulation. 8. As soon as practicable after an entry of judgment reflecting a decision consistent with the terms of this Stipulation, and after petitioner has filed an election to receive compensation pursuant to 42 U .S.C. § 300aa-21 (a)(l ), the Secretary of Health and Human Services will issue the following vaccine compensation payment: A lump sum of $30,000.00 to be paid through an ACH deposit to petitioner's counsel's IOLTA account for prompt disbursement to petitioner. This amount represents compensation for all damages that would be available under 42 U.S.C. § 300aa-15(a). 9. As soon as practicable after the entry of judgment on entitlement in this case, and after petitioner has filed both a proper and timely election to receive compensation pursuant to 42 U.S.C. § 300aa-21 (a)(l ), and an application, the parties will submit to further proceedings before the special master to award reasonable attorneys' fees and costs incurred in proceeding upon this petition. Page 2 of 6 Case 1:24-vv-00060-UNJ Document 38 Filed 10/31/25 Page 5 of 8 10. Petitioner and her attorney represent that they have identified to respondent all known sources of payment for items or services for which the Program is not primarily liable under 42 U.S.C. § 300aa-15(g), including State compensation programs, insurance policies, Federal or State health benefits programs ( other than Title XIX of the Social Security Act ( 42 U.S.C. § 1396 et seq.)), or entities that provide health services on a prepaid basis. 11. Payment made pursuant to paragraph 8 of this Stipulation and any amounts awarded pursuant to paragraph 9 will be made in accordance with 42 U.S.C. § 300aa-l 5(i), subject to the availability of sufficient statutory funds. 12. The parties and their attorneys further agree and stipulate that, except for any award for attorneys' fees and litigation costs, the money provided pursuant to this Stipulation will be used solely for the benefit of petitioner as contemplated by a strict construction of 42 U.S.C. § 300aa l 5(a) and ( d), and subject to the conditions of 42 U.S.C. § 300aa-15(g) and (h). 13. In return for the payments described in paragraphs 8 and 9, petitioner, in her individual capacity, and on behalf of her heirs, executors, administrators, successors, and assigns, (a) does forever irrevocably and unconditionally release, acquit and discharge the United States and the Secretary of Health and Human Services from any and all actions or causes of action (including agreements, judgments, claims, damages, loss of services, expenses and all demands of whatever kind or nature) that have been brought, could have been brought, or could be timely brought in the United States Court of Federal Claims, under the National Vaccine Injury Compensation Program, 42 U.S.C. § 300aa-l O et seq., (i) on account of, or in any way growing out of, any and all known or unknown, suspected or unsuspected personal injuries to or death of petitioner resulting from, or alleged to have resulted from, the Tdap vaccination administered on or about October 20, 2022, and (ii) that petitioner has had, now has, or hereafter may have with respect to the injury that gave Page 3 of 6 Case 1:24-vv-00060-UNJ Document 38 Filed 10/31/25 Page 6 of 8 rise to the petition for vaccine compensation filed on or about January 17, 2024, in the United States Court of Federal Claims as petition No. 24-60V; and (b) waives any and all rights to any compensation that may be available under the Countermeasures Injury Compensation Program (CICP), 42 U.S.C. § 247d-6e (or an action under 42 U.S.C. § 247d-6d(d)), for a claim alleging that a covered countermeasure, including the COVID-19 vaccination administered on January 6, 2023, on its own or in combination with the Tdap vaccination administered on October 20, 2022, caused or seriously aggravated the injuries that were the subject of the petition for vaccine compensation filed on or about January 17, 2024, in the United States Court of Federal Claims as petition 24- 60V, including a SIRVA for which petitioner will receive compensation pursuant to this Stipulation. If petitioner has such a claim currently pending with the CICP, petitioner hereby withdraws such claim for compensation in the CICP.2 If no claim for compensation has been filed in the CICP as of the date this Stipulation is filed, petitioner waives the right to file a claim as described in this paragraph for compensation in the CICP. 14. If petitioner should die prior to entry of judgment, this agreement shall be voidable upon proper notice to the Court on behalf of either or both of the parties. 15. If the special master fails to issue a decision in complete conformity with the terms of this Stipulation or if the United States Court of Federal Claims fails to enter judgment in conformity with a decision that is in complete conformity with the terms of this Stipulation, then the pa11ies' settlement and this Stipulation shall be voidable at the sole discretion of either party. 16. This Stipulation expresses a full and complete negotiated settlement of liability and damages claimed under the National Childhood Vaccine Injury Act of 1986, as amended, except 2 After entry of judgment reflecting a decision consistent with the terms of this Stipulation, petitioner agrees that respondent will send this Stipulation to the CICP as evidence of petitioner's withdrawal of their CICP claim and waiver of any potential compensation under the CICP. Page 4 of 6 Case 1:24-vv-00060-UNJ Document 38 Filed 10/31/25 Page 7 of 8 as otherwise noted in paragraph 9 above. There is absolutely no agreement on the part of the parties hereto to make any payment or do any act or thing other than is herein expressly stated and clearly agreed to. The parties further agree and understand that the award described in this Stipulation may reflect a compromise of the parties' respective positions as to liability and/or amount of damages, and further, that a change in the nature of the injury or condition or in the items of compensation sought, is not grounds to modify or revise this agreement. 17. This Stipulation shall not be construed as an admission by the United States or the Secretary of Health and Human Services that the Tdap vaccine caused petitioner's alleged shoulder injury or any other injury or any of her current disabilities. 18. All rights and obligations of petitioner hereunder shall apply equally to petitioner's heirs, executors, administrators, successors, and/or assigns. END OF STIPULATION Page 5 of 6 Case 1:24-vv-00060-UNJ Document 38 Filed 10/31/25 Page 8 of 8 Respectfully submitted, PETITIONER: uk-it-~,ud~ ~. . n..✓ AMANDA CONNOR ATTORNEY OF RECORD FOR AUTHORIZED REPRESENTATIVE /b-L_ OF THE ATTORNEY GENERAL: PETIT~ 4&e t±:MuA-'tl-- p ~ I CHRIS J. WEBB HEATHER L. PEARLMAN BLACK MCLAREN JONES RYLAND & GRIFFEE Deputy Director 530 Oak Court Drive Torts Branch Suite 360 Civil Division Memphis, TN 38117 U.S. Department of Justice Tel: (901) 762-0535 P.O. Box 146 Email: cwebb@blackmclaw.com Benjamin Franklin Station Washington, DC 20044-0146 AUTHORIZED REPRESENTATIVE OF ATTORNEY OF RECORD FOR THE SECRETARY OF HEALTH AND RESPONDENT: HUMAN SERVICES: Jeffreys. Digitally signed by ~ G CVU"'~>t-( Jeffrey 5. Beach -5 Be ac h - S Date: 2025.09.10 h ~~ ~y>e..~ 12:50:44-04'00' for CAPT GEORGE REED GRIMES, MD, MPH MALLORI B. OPENCHOWSKI Director, Division of Injury Trial Attorney Compensation Programs Torts Branch, Civil Division Health Systems Bureau U.S. Department of Justice Health Resources and Services P.O. Box 146 Administration Benjamin Franklin Station U.S. Department of Health Washington, D.C. 20044-0146 and Human Services Tel: (202) 305-0660 5600 Fishers Lane, 14W-18 mallori. b.openchowski@usdo j .gov Rockville, MD 20857 Dated: oq f 1 ,-3 /uJuS Page 6 of 6